A Worldwide Pregnancy Safety Study to Assess Maternal, Foetal, and Infant Outcomes Following Exposure to Efgartigimod alfa during Pregnancy and/or Breastfeeding First published 26/02/2024 Last updated 02/04/2025 EU PAS number:EUPAS1000000005 Study Ongoing